These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 36660710

  • 1. Prognostic analysis of RAS-related lncRNAs in liver hepatocellular carcinoma.
    Li D, Fan X, Zuo L, Wu X, Wu Y, Zhang Y, Zou F, Sun Z, Zhang W.
    Ann Transl Med; 2022 Dec; 10(24):1356. PubMed ID: 36660710
    [Abstract] [Full Text] [Related]

  • 2. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
    Yang T, Luo Y, Liu J, Liu F, Ma Z, Liu G, Li H, Wen J, Chen C, Zeng X.
    Front Oncol; 2023 Dec; 13():1182434. PubMed ID: 37346073
    [Abstract] [Full Text] [Related]

  • 3. Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma.
    Wang X, Qian J, Yao N, Pocha C, Kang KJ, Angelico R, Zhu G.
    Ann Transl Med; 2022 May; 10(10):595. PubMed ID: 35722420
    [Abstract] [Full Text] [Related]

  • 4. Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma.
    Wei W, Liu C, Wang M, Jiang W, Wang C, Zhang S.
    Front Genet; 2022 May; 13():906496. PubMed ID: 35938009
    [Abstract] [Full Text] [Related]

  • 5. Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma.
    Tang P, Qu W, Wang T, Liu M, Wu D, Tan L, Zhou H.
    Front Genet; 2021 May; 12():785185. PubMed ID: 34917132
    [Abstract] [Full Text] [Related]

  • 6. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma.
    Wang L, Ge X, Zhang Z, Ye Y, Zhou Z, Li M, Yan H, Wu L, Bai Q, Li J, Zhu J, Wang Y.
    Front Genet; 2021 May; 12():682082. PubMed ID: 34745200
    [Abstract] [Full Text] [Related]

  • 7. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
    Zhang Z, Wang J, Han W, Zhao L.
    BMC Gastroenterol; 2023 Apr 20; 23(1):132. PubMed ID: 37081402
    [Abstract] [Full Text] [Related]

  • 8. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
    Wang R, Hu X, Liu X, Bai L, Gu J, Li Q.
    PLoS One; 2021 Apr 20; 16(4):e0249881. PubMed ID: 33861762
    [Abstract] [Full Text] [Related]

  • 9. Tumor necrosis factor-related lncRNAs predict prognosis and immunotherapy response for patients with lung adenocarcinoma.
    Chen JH, Wu X, Wang ZM, Liu ZY, He BX, Song WP, Zhang WZ.
    J Thorac Dis; 2023 Mar 31; 15(3):1373-1386. PubMed ID: 37065578
    [Abstract] [Full Text] [Related]

  • 10. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival.
    Liu P, Dong C, Shi H, Yan Z, Zhang J, Liu J.
    J Gastrointest Oncol; 2022 Dec 31; 13(6):3169-3182. PubMed ID: 36636051
    [Abstract] [Full Text] [Related]

  • 11. A disulfidptosis-related lncRNAs signature in hepatocellular carcinoma: prognostic prediction, tumor immune microenvironment and drug susceptibility.
    Liu Y, Meng J, Ruan X, Wei F, Zhang F, Qin X.
    Sci Rep; 2024 Jan 07; 14(1):746. PubMed ID: 38185671
    [Abstract] [Full Text] [Related]

  • 12. Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs.
    Dai YY, Gao YP, Chen LX, Liu JS, Zeng C, Zhou JD, Wu HL.
    Front Genet; 2022 Jan 07; 13():930446. PubMed ID: 36110218
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic Value of an Immune Long Non-Coding RNA Signature in Liver Hepatocellular Carcinoma.
    Kong R, Wang N, Zhou CL, Lu J.
    J Microbiol Biotechnol; 2024 Apr 28; 34(4):958-968. PubMed ID: 38494878
    [Abstract] [Full Text] [Related]

  • 18. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y, Wei X, Han Q, Le J, Ma Y, Lin X, Xu Y, Liu N, Wang X, Kong X, Gu J, Tong Y, Wu H.
    BMC Cancer; 2021 Oct 30; 21(1):1165. PubMed ID: 34717566
    [Abstract] [Full Text] [Related]

  • 19. A prognostic exosome-related long non-coding RNAs risk model related to the immune microenvironment and therapeutic responses for patients with liver hepatocellular carcinoma.
    Yue Y, Tao J, An D, Shi L.
    Heliyon; 2024 Jan 30; 10(2):e24462. PubMed ID: 38293480
    [Abstract] [Full Text] [Related]

  • 20. Comprehensive analysis of N6 -methyladenosine-related long non-coding RNAs for prognosis prediction in liver hepatocellular carcinoma.
    Zhu HX, Lu WJ, Zhu WP, Yu S.
    J Clin Lab Anal; 2021 Dec 30; 35(12):e24071. PubMed ID: 34741346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.